Atypical antipsychotics:

analysis of adverse events

Autores/as

  • Claudia Aparecida Avelar Ferreira CENTRO UNIVERSITARIO UNA, FUMEC,FHEMIG
  • Isabelle Cristina de Oliveira Santos
  • Hairton Ayres Azevedo Guimarães
  • Maisa Aparecida Guatimosim Azevedo
  • Waldirce Inêz de Souza

Resumen

The aim was to identify adverse events arising from the continued use of atypical antipsychotics through cohort and case control studies, carried out on a worldwide level, in the period from 2013 and 2014. Method: A literature review was performed from an exploratory study seeking cohort and case control studies about atypical antipsychotics with bibliometrics application according to Bradford's Law. Results: The study resulted in 291 surveyed articles, of which 18 were selected and analyzed. Conclusion: the main findings were cardiovascular risk, QT interval prolongation, diabetes, increased body mass index, extrapyramidal effects.

Biografía del autor/a

  • Claudia Aparecida Avelar Ferreira, CENTRO UNIVERSITARIO UNA, FUMEC,FHEMIG

    Mestre em Administração(UNA). Especialista em Saúde Pública e Administração de Serviços de Saúde(UNAERP), Assistência farmacêutica no SUS(UFSC) e MBA em gestão de organizações hospitalares e serviços de saúde(FGV).

Descargas

Número

Sección

Artigos de Revisão

Cómo citar

1.
Atypical antipsychotics:: analysis of adverse events. Rev. G&S [Internet]. 2015 Oct. 6 [cited 2025 Dec. 28];6(3):Pág. 2870-2883. Available from: https://periodicostestes.bce.unb.br/index.php/rgs/article/view/3275

Artículos más leídos del mismo autor/a